摘要
目的:通过转染技术抑制或增强SMYD3基因的表达,以探讨SMYD3对乳腺癌MCF-7细胞增殖的调控机制机制。方法:以MTT法和软琼脂克隆形成实验研究抑制或增强SMYD3基因表达对细胞增殖的影响,以RT-PCR法和Western印迹法检测MCF-7细胞经转染后,胞内SMYD3、ERK/MAPK通路相关蛋白及其磷酸化产物,以及凋亡和细胞周期调控相关蛋白表达水平的变化。结果:用针对SMYD3基因的shRNAs表达质粒转染MCF-7细胞后,其SMYD3基因mRNA和蛋白表达水平下调,细胞生长受到抑制,细胞中ERK1/2、CyclinD1和CDK4蛋白水平明显下调;软琼脂克隆形成实验显示,增强SMYD3基因表达能明显促进MCF-7细胞克隆形成。结论:SMYD3可通过激活ERK/MAPK信号转导通路和上调细胞周期相关蛋白CyclinD1和CDK4的水平提高肿瘤细胞的增殖能力。
Objective: To study the function of SMYD3 in the proliferation regulation of human breast cancer MCF-7 cells by inhibiting or activating the expression of SMYD3 gene by transfection technique. Methods: The MTT assay and soft agar cloning assay were used to explore the influence of SMYD3 gene inhibition and activation on MCF-7 cell proliferation. RT-PCR and Western blot assays were conducted to investigate the intracellular expression levels of SMYD3, ERK/MAPK pathway related proteins, as well as apoptosis and cell circle regulation related proteins, after gene transfection. Results: After SMYD3 shRNA expression vector was transfected into MCF-7 cells, the SMYD3 gene transcription level and the SMYD3 expression level were down-regulated greatly, and the growth of the cells was inhibited. Besides, down-regulation of the expression levels of ERK1/2, CyclinDl and CDK4 was also observed in MCF-7 cells, in which the SMYD3 gene expression was inhibited. The soft agar cloning assay demonstrated that the clone number of MCF-7 cells rised obviously after the activation of SMYD3 gene. Conclusion: SMYD3 could promote the proliferation of tumor cells via activating the MAPK/ERK pathway and up-regulating the expression levels of CyclinD1 and CDK4.
出处
《药学进展》
CAS
2012年第2期73-79,共7页
Progress in Pharmaceutical Sciences